The regulation of molecular farming is a complex topic because plants and plant-based systems are relative newcomers among the many production platforms available for recombinant proteins. The regulations specific for different types of product (human/veterinary pharmaceuticals and medical devices, cosmetics, diagnostics, and research reagents) must therefore be overlaid with the regulations governing hitherto unfamiliar production platforms, and this must be achieved in different jurisdictions that handle genetically modified organisms (and genetically modified plants in particular) in very different ways. This chapter uses examples of different product types and production methods in three different jurisdictions (the USA, the EU, and Canada) to demonstrate some of the challenges facing the regulatory authorities.
Keywords: Cosmetic; Diagnostic; GMO; Good manufacturing practice; Medical device; Pharmaceutical; Plant cells; Research reagent; Transgenic plants; Transient expression.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.